CAI FY 2009 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$65M-21.5% YoY

Gross Profit

$57M86.6% margin

Operating Income

$23M35.0% margin

Net Income

$14M20.8% margin

EPS (Diluted)

$0.76

Cash Flow

Operating Cash Flow

$31M

Free Cash Flow

-$555,000

Stock-Based Comp.

$992,000

Balance Sheet

Total Assets

$374M

Total Liabilities

$245M

Stockholders' Equity

$129M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$65M	$83M	-21.5%
Gross Profit	$57M	$78M	-27.8%
Operating Income	$23M	$44M	-48.4%
Net Income	$14M	-$27M	+150.3%